• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Lyme Disease Research Center

Show Search
Hide Search
  • Lyme Disease
    • Signs & Symptoms of Lyme Disease
    • Diagnosis of Lyme Disease
    • Lyme Disease Treatment and Prognosis
    • Lyme Disease Prevention, Tick Removal, & Health and Wellness Tips
    • Frequently Asked Questions (FAQs)
    • Lyme Disease Video Introduction Series
    • Lyme Disease Video Education Resources
  • About the Center
    • Meet Our Team
    • Make an Appointment
    • Address & Directions
    • Refill a Prescription
    • Lyme and Tickborne Disease Fellowship Program
    • Subscribe to Our Email Newsletter
  • News & Impact
    • Impact Report
    • Newsletters
    • Research News
    • In The News
    • Talks by John Aucott, MD
    • Subscribe to Our Email Newsletter
  • Research Studies
    • Research Publications
    • Open Research Studies
    • Lyme Disease Epidemiology
  • Make a Gift
  • Newsletter Signup
Home / Lyme Disease Research / Cognitive Decline in Post-treatment Lyme Disease Syndrome

Cognitive Decline in Post-treatment Lyme Disease Syndrome

July 3, 2018 By Johns Hopkins Lyme Disease Research Center

Summary

Patients with Post-treatment Lyme Disease Syndrome (PTLDS) commonly complain of cognitive symptoms. However, prior studies assessing neuropsychological functioning in this population have varied both in terms of patient selection criteria and the significance of their findings. This study sought to assess objective cognitive functioning status in a well-defined sample of patients with PTLDS. The study found, in subsets of PTLDS patients, objective evidence of cognitive decline in verbal memory and processing speed, cognitive impairment, and sub-optimal engagement with testing.

Why was this study done?

Patients with post-treatment Lyme disease syndrome (PTLDS) commonly complain of cognitive symptoms, however prior studies assessing neuropsychological functioning in this population have varied. This study was done to systematically examine and measure cognitive functioning of patients with PTLDS, using standardized testing instruments.

How was this study done?

The study enrolled 124 patients with confirmed PTLDS defined by the Infectious Diseases Society of America’s proposed case definition. Cognitive functioning was evaluated using standardized neuropsychological measures of attention, memory, processing speed, and test engagement.

What were the major findings?

The majority (92%) of participants with PTLDS reported symptoms of cognitive difficulty to some degree. Objective evidence of cognitive decline (compared to estimated pre-morbid function) was identified in 26% of participants, with the most robust findings in verbal memory and processing speed. A subset (22% of those with decline) also showed objective evidence of cognitive impairment compared to population-level performance. Despite subjective symptoms, 50% of the sample showed no statistically or clinically significant objective decline in cognitive function using standardized neuropsychological measures. The remaining 24% of the sample were found to have sub-optimal engagement on testing measures, which may be due to the impact of fatigue, pain, prior negative clinical experiences, or other unknown factors.

What is the impact of this work?

The current findings support objective evidence of cognitive decline and impairment in subsets of patients with PTLDS in distinct areas of cognitive functioning, especially verbal memory and processing speed. Further studies are needed to better understand the patient subjective experience of cognitive decline as well as the factors associated with objective cognitive decline to better manage symptoms of PTLDS and improve health related quality of life.

This research was supported by:

The research was supported by The Lyme Disease Research Foundation and the Steven and Alexandra Cohen Foundation.

Link to the original research article:

Cognitive Decline in Post-treatment Lyme Disease Syndrome – Pegah Touradji, John N Aucott, Ting Yang, Alison W Rebman, Kathleen T Bechtold; Cognitive Decline in Post-treatment Lyme Disease Syndrome, Archives of Clinical Neuropsychology, , acy051,

Receive the Latest News from the Johns Hopkins Lyme Disease Research Center

Receive the Latest News from the Johns Hopkins Lyme Disease Research Center

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology and the Johns Hopkins Lyme Disease Research Center.

Interested In

You have Successfully Subscribed!

Filed Under: Lyme Disease Research, Lyme Disease Research Highlights Tagged With: Lyme Disease

Johns Hopkins Lyme Disease Research Center

Johns Hopkins Lyme Disease Research Center

The Johns Hopkins Lyme Disease Research Center is focused on patient-based research in all manifestations of Lyme disease. Our goal is to translate our pioneering research into improved patient care, education, and health outcomes.

Use of This Site

All information contained within the Johns Hopkins Lyme Disease Research Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

  • About the Center
  • Lyme Disease Information
  • Meet Our Team
  • Our Research
  • Support Our Work

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Arthritis Center
  • Lupus Center
  • Myositis Center
  • Scleroderma Center
  • Sjögren’s Syndrome Center
  • Vasculitis Center

Connect with Us

  • Facebook
  • Twitter
  • YouTube

U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2023 Johns Hopkins Lyme Disease Research Center
Patient Privacy